CHESSMEN Joint Action

Welcome to interactive presentation, created with Publuu. Enjoy the reading!

CHESSMEN

JOINT ACTION

PARTICIPATION IN EU-JAMRAI 2,

JOINT ACTION ON

ANTIMICROBIAL RESISTANCE &

HEALTHCARE-ASSOCIATED

INFECTIONS

CHESSMEN participated in the kick-off

meeting of the EU-JAMRAI 2 Joint Action on

Antimicrobial Resistance & Healthcare-

Associated Infections.

This marked an important step on the

coordination and harmonization of best

practices, while avoiding the duplication of

efforts.

Date: 13 February 2024

Location: Paris, France

CHESSMEN RADAR: WPS

VIDEO UPDATES

The Joint Action launched the new initiative

‘CHESSMEN Radar’, a resource to assist in the

dissemination of information given directly by

the WP Leaders.

This initiative comprises one-minute videos

regarding the accomplishments, ongoing work

and foreseen deliverables of each WP.

Date: January/May 2024

Location: Online

WRAP-UP 2024

Co-funded by

the European Union

PARTICIPATION IN

THE INTERNATIONAL

CONFERENCE ON THE

‘THE SUPPLY OF

PLASMA-DERIVED

MEDICINAL

PRODUCTS IN THE

FUTURE OF EUROPE’

EVENT HIGHLIGHTS

CHESSMEN participated in the International

Conference on the ‘Supply of Plasma-Derived

Medicinal Products in the Future of Europe’,

hosted by Centro Nazionale Sangue.

Date: 23/24 April 2024

Location: Rome, Italy

AEMPS STUDY VISIT: MEDICINE

SHORTAGE MANAGEMENT

STRATEGIES

The Spanish Agency of Medicines and Medical

Devices (AEMPS) hosted in their headquarters

representatives from INFARMED, I.P,, JAZMP,

and AIFA for a study visit.

This meeting led to a comprehensive

understanding of the tools, methodologies and

procedures used by AEMPS for the prevention,

management and monitoring of shortages.

Dates: 22/24 May 2024

Location: Madrid, Spain

Key highlights:

CHESSMEN speakers shared insights on the ongoing work, deliverables and

milestones.

Emphasis on the importance of ensuring medication access for all patients,

particularly blood-derived medicines.

The main results of the supply project, co-funded by EU4Health programme, were

presented.

Framework discussions on different work packages in advancing healthcare

accessibility.

Joint effort and alignment of objectives between both initiatives.

Periodical meetings have been held since April, 2024.

CHESSMEN JOINT ACTION

INTERMEDIATE MEETING

A key milestone in the Joint Action, that

gathered all CHESSMEN beneficiaries.

The two-day meeting, started on June 17 with

a closed session for WP leaders, followed on

June 18 by an open session for all members.

Key highlights:

Update on project progress and challenges.

Presentations from WP leaders on

accomplishments, ongoing work, future

deliverables and milestones.

Identification of main constrains.

Insightful participation from the European

Commission and European Medicines

Agency.

Dates: 19/21 June 2024

Location: Lisbon, Portugal

INFARMED, I.P. STUDY VISIT:

MEDICINE SHORTAGE

MANAGEMENT STRATEGIES

The Portuguese National Authority of

Medicines and Health Products, I.P.

(INFARMED, I.P.) hosted in their headquarters

representatives from Finland, Italy, Slovenia,

the Netherlands, and Spain.

Discussions focused on the tools, databases,

procedures and methodologies used in

Portugal. Key areas for improvement were

identified for future CHESSMEN meetings.

Dates: 19/21 June 2024

Location: Lisbon, Portugal

CHESSMEN WP7 MEETING IN

BONN

Key objectives included:

Further elaboration of the draft framework

for a concept platform to monitor and

manage medicine shortages

Discussion on the definitions of data

elements included in the required common

dataset

Updates on the progress of deliverables

from other WPs

Agreement on next steps

Date: 4/5 November 2024

Location: Bonn, Germany and online

MULTI-STAKEHOLDER

WORKSHOP

The Slovenian Agency for Medicinal Products and

Medical Devices (JAZMP), convened CHESSMEN

Multi-stakeholder Workshop bringing together

representatives of industry, healthcare

professionals, patient and consumer advocates, as

well as representatives from national regulatory

authorities and other European regulatory bodies.

The virtual workshop was attended by 220

participants and offered key stakeholders in supply

chain an opportunity to discuss the current state,

key findings, and preliminary conclusions of four

technical Work Packages of CHESSMEN JA after

almost 2 years of intensive cooperation supporting

harmonised response to medicines shortages in

EU/EEA.

Date: 27 November 2024

Location: Online

CHESSMEN JA INSYNC

WORKSHOP

The first session was directed to CHESSMEN

beneficiaries and explored the experience and

insights of 3 National Competent Authorities:

AEMPS, AIFA, and INFARMED I.P.

Key highlights:

Institutional organizational charts

Team’s competencies, training and

assigned roles

National initiatives and resources

National mechanisms for managing

medicine shortages

Q&A

Date: 19 December 2024

Location: Online

TECHNICAL DELIVERABLES

COMPLETED BY THE END OF

2024

D 5.1: List of Key Definitions Relating to Medicine Shortages

Dissemination level: Sensitive

This deliverable clarified key definitions related to medicine shortages, with the goal to

walk towards increased standardization of the terminology used across EU Member

States. This deliverable was fundamental to clarify key definitions early in the project.

D 5.2: Review on Existing Documents or Information Relating to Root

Causes of Medicine Shortages in the EU

Dissemination level: Sensitive

A comprehensive review of existing documents and information related to the root

causes of medicine shortages in EU Member States.

D 5.3: Analysis Report on Root Causes

Dissemination level: Public

Based on the work developed on D 5.2 and supported by information obtained from

surveys of both Consortium partners and external target groups to address information

gaps, a report was elaborated on the analysis and categorisation of root causes of

medicine shortages in EU Member States.

D 6.1: Report on the Existing Documents on Shortages of Medicines

Dissemination level: Sensitive

A report of collected existing documents, such as guidelines, legislation, and reports

from Member States and key organisations covering medicine shortages.

D 7.1: Analysis Report on the IT Solutions at EU and MS

Dissemination level: Sensitive

An analysis of existing IT solutions at both EU and MS level for shortage notification and

monitoring, identifying strengths, weaknesses, opportunities, threats, and country-

specific data sources beyond national Competent Authorities.

D 7.2: Report on EU Best Practice Solutions and Minimum Common

Datasets

Dissemination level: Public

Based on the analysis of existing IT tools at national and European level, best practice

solutions and minimum common datasets have been identified.

For more information, visit: CHESSMEN website

Contact us at: jachessmen@gmail.com

1 2 3 4 5

Made with Publuu - flipbook maker